Showing results (91-100 of 118) with videos related to
Sort By:
Pageof 12
Diabetology & Metabolic Syndrome|December 22, 2025
Statin therapy on dementia in elderly type 2 diabetes patients with deliriumMingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.Journal of Parkinson'S Disease|July 17, 2025
SGLT2 inhibitors vs. metformin for Parkinson's disease risk reduction in type 2 diabetesMingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.The Journal of Clinical Psychiatry|August 6, 2025
Delirium as a Precursor to Dementia in Elderly Type 2 Diabetes Mellitus PatientsMingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.Diabetes, Obesity & Metabolism|April 11, 2025
Sodium-glucose cotransporter-2 inhibitors and subtype-specific dementia risk: A multinational and multiethnic cohort studyMingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.Diabetology & Metabolic Syndrome|May 29, 2026
Metformin versus DPP-4 inhibitors and risk of parkinsonism in type 2 diabetes: an active-comparator cohort study with a landmark designMingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 24, 2023
Statin use reduces radiation-induced stroke risk in advanced nasopharyngeal carcinoma patientsChuan-Yi Lin, Chia-Lun Chang, Kuan-Chou Lin, et al.Liver International : Official Journal of the International Association for the Study of the Liver|June 29, 2023
Protective effects of statins on the incidence of NAFLD-related decompensated cirrhosis in T2DMSzu-Yuan Wu, Wan-Ming Chen, Ming-Feng Chiang, et al.Cancer Treatment and Research Communications|July 18, 2026
The potential role of oligo-fucoidan as a bioactive adjunct in oncology: a personal view on mechanistic insights and therapeutic continuityKuan-Chou Lin, Jung-Min Yu, Chia-Lun Chang, et al.Diabetes, Obesity & Metabolism|July 2, 2024
Metformin monotherapy versus predominantly older non-metformin antidiabetic medications for cerebrovascular risk in early type 2 diabetes managementMingyang Sun, Zhongyuan Lu, Wan-Ming Chen, et al.Atherosclerosis|February 4, 2025
N-acetylcysteine therapy reduces major adverse cardiovascular events in patients with type 2 diabetes mellitusMingyang Sun, Zhongyuan Lu, Wan-Ming Chen, et al.Pageof 12